Regulatory News
Friday, May 20, 2016
BRIEF-Anavex announces U.S. FDA orphan drug designation to anavex 2-73
* Announces U.S. FDA orphan drug designation to anavex 2-73
for the treatment of rett syndrome
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1 646 223 8780)
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment